HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jin-Yi Chang Selected Research

Albumins

4/2022Cardiotoxicity monitoring of pyrotinib in combination with nab-paclitaxel, doxorubicin, and cyclophosphamide in HER2-positive breast cancer: a single-armed clinical trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jin-Yi Chang Research Topics

Disease

3Breast Neoplasms (Breast Cancer)
02/2023 - 12/2021
1Hemorrhage
04/2023
1Edema (Dropsy)
04/2023
1Phlebitis
02/2023
1Cardiotoxicity
04/2022
1Neoplasms (Cancer)
12/2021
1Diarrhea
12/2021
1Exanthema (Rash)
12/2021
1Hand-Foot Syndrome
12/2021

Drug/Important Bio-Agent (IBA)

3pyrotinibIBA
02/2023 - 12/2021
3human ERBB2 proteinIBA
02/2023 - 12/2021
2130-nm albumin-bound paclitaxelIBA
04/2022 - 12/2021
2Doxorubicin (Adriamycin)FDA LinkGeneric
04/2022 - 12/2021
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2022 - 12/2021
2liposomal doxorubicin (Doxil)FDA Link
04/2022 - 12/2021
1N-acetyltalosaminuronic acid (NAT)IBA
02/2023
1Capecitabine (Xeloda)FDA Link
02/2023
1Paclitaxel (Taxol)FDA LinkGeneric
04/2022
1AlbuminsIBA
04/2022

Therapy/Procedure

2Neoadjuvant Therapy
02/2023 - 12/2021
1Operative Time
04/2023
1Radiotherapy
04/2023
1Drug Therapy (Chemotherapy)
02/2023